- Baptist Memorial cuts length of stay 14%, doubles transfer volume
- 20 most socially responsible hospitals, according to Lown
- Medicare’s AI Push Snarls Patients and Doctors in Errors and Delays
- Worried About Your Aging Parents? Welcome to the Caregiving Club
- Albany Med Health System eyes affiliation with Ellis Medicine
- 1.4 million patients, 7 health systems caught in AI company data breach
- Banner Health clinicians file to unionize
- New Hampshire system names new chief strategy officer
- 8 recent studies on AI in diagnosis and clinical reasoning
- HHS launches Operation TrailBlazer to speed clinical trials: 5 notes
- Iowa 1st to fully allocate year 1 rural health funds
- ‘I would love to tell Mark Cuban to get involved’: What physician consolidation is costing patients
- Illinois passes bill regulating dental reimbursement practices
- The shifting dental care landscape
- Duke Health names ophthalmology chair
- Harvard to end faculty dental practice, transfer clinic to private owner due to financial constraints
- A physician’s plan to bring back practice autonomy to South Carolina
- Cardiologists push back on expansion of WISeR model
- Are ASCs ready for CMS’ new oversight rules?
- MCNA Dental agrees to multimillion-dollar settlement over 2023 ransomware attack
- Former Iowa dental office employee accused of using patient financial information for personal purchases
- Optum Behavioral Health names chief medical officer
- Stark law’s $632 million reckoning: The 5 biggest cases in 5 years
- ASCs’ robot evidence problem
- United Concordia expands dental coverage for patients with chronic conditions
- Who’s winning, losing the physician practice acquisition race?
- OIG flags Pennsylvania behavioral insurer for faulty prior auth denials
- Independence Health to open 28-bed behavioral health unit
- ICON Dental Partners appoints VP of dental partnerships
- These 'socially responsible' hospitals deliver on quality, value and equity
- A look at Elevance Health's push to streamline clinical reviews
- Heartland Dental adds Missouri practice
- 4 dentists making headlines
- Growing ketamine use raises safety concerns
- AI’s growing role in mental healthcare: 5 notes
- Does ASC consolidation have a ceiling?
- Washington lawmakers eye corporate medicine ban after Oregon’s PeaceHealth test
- Pennsylvania cardiology group opens new $8.2M ASC
- Patient portal messages doubled since 2020, study finds, underscoring challenges to physician workloads
- HCSC unveils Easify Edge plans as alternative employer option
- Clover Hill Dairy Recalls All Cheese in Deadly Listeria Outbreak
- Ensemble Health Partners secures strategic growth investment from Thoreau
- Hospital margins inched higher in April, but still remain below 2025
- Middle-Aged Women Drink More, Know Less About Breast Cancer Risk
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- CARsgen makes history as China approves world's first CAR-T therapy for solid tumors
- High Hurdles Thwart Kidney Patients' Pursuit Of Life-Saving Transplants
- Rising Healthcare Costs Leave Many Americans Less Secure
- Short Videos Help First-Time Dads Learn Newborn Safety Basics
- Federal Push To Increase U.S. Primary Care Docs Has Fizzled, Study Says
- US to investigate Germany's proposed drug spending reforms
- Alnylam scolded over promotional activity after Pfizer complaint
- They're Uninsured After Obamacare Became Too Costly. And They're Far From Alone.
- Indiana Takes On Powerful Hospitals by Capping Prices They Charge Employers
- Prosper AI lands $30M backed by Andreessen Horowitz to build AI workforce for healthcare operations
- Eli Lilly, Novo Nordisk top AI citation share as new report questions DTC spend culture
- Fish Oil Supplements May Be A Bust For Alzheimer's Prevention
- Prehab Can Boost Seniors' Recuperation From Spinal Fusion Surgery, Trial Finds
- Ozempic Might Cut Risk Of Broken Bones, Study Says
- Dog Owners Feel Similar Grief Whether Pets Euthanized, Die Naturally
- Massage Guns Can Cause Eye Damage, Vision Loss, Case Report Warns
- A 5-month sprint: Behind Pfizer’s $10B deal and Innovent’s global pharma ambition
- 1st free dental clinic opens in New Jersey
- 8 new behavioral health projects to know
- Oregon prosecutors urge state to fix mental health system
- The case for layering behavioral healthcare models
- Rural, independent Kansas hospitals launch clinically integrated network
- 12 behavioral health services, facility closures | 2026
- Higher, short-acting opioid doses linked to 8% lower discharge risk: 4 notes
- FTC orders Aurobindo to divest 4 drugs to complete $250M Lannett acquisition
- Congressional Budget Office calls for more research on No Surprises Act unintended impacts
- HHS opens applications for $700M in mental health, addiction funding, with $96M for new STREETS program
- Ebola Infections Climb, Could Take Year To Contain, Health Officials Say
- Why a deviation investigation still takes two weeks in the age of AI
- Feeling Sleepy During the Day? It Could Be a Warning Sign for High Blood Pressure
- FTC, states sue transgender health association over 'misleading' gender care guidance
- Healthcare organizations still struggle to operationalize AI at scale: Arcadia survey
- Pfizer hunts for new CFO as Denton prepares to hang up gloves, wave goodbye to pharma
- Major League Pitchers Might Avoid Elbow Injuries By Altering Their Approach, Simulation Suggests
- Birth Control Pills Might Increase Binge Eating Risk, Study Finds
- Women Might Lower Their Heart Risk By Lifting Weights, Study Says
- Personalized Brain Implant Provides Step-By-Step Walking Boost For Parkinson's Patients
- Amid industry’s cell therapy automation push, Cellares and Ori dominate the field: report
- Most Americans Are Surviving Cancer. But The Mental Health Challenges Can Persist.
- Listen to the Latest ‘KFF Health News Minute’
- Readers Curse Medical Debt and Defend Spelling Therapy
- Arrests of Immigrant Parents Create Mental Health Crisis for Children
- Sandwiched Between Caring for Kids and Aging Parents? Reach Out for Resources
- Novo's success with oral Wegovy has been fueled by 'familiarity': Spherix
- Preparing for LEAD: Why post-acute visibility is the key to long-term value-based success
- One Medical Seniors reports data breach of third-party vendor impacting 'limited' number of patients
- A look at Epic's long-term play to build tech for operations, starting with scheduling
- U.K. Moves To Ban Social Media For Children
- Pregnant Woman Exposed to 45 Common Chemicals, Study Finds
- OhioHealth reaches settlement with DOJ, Ohio AG on antitrust lawsuit
- 4 years after snub, GSK partnership helps Spero get Utebzi across FDA finish line
- Despite 'decent' data, Verastem rethinks options for approved oncology combo in pancreatic cancer
- OIG report raises red flags about maternal health 'ghost networks' in Medicaid managed care
- Why It’s Time to Sunset AI Point Solutions and Consolidate Platforms
- Lantern, Marathon Health team up to launch integrated care management model
- The New Frontier of Care Management: Bridging the Empathy Gap with Intelligence
- Novo Nordisk opens Czech plant and unveils $29M upgrade to China facility
- Whoop, HealthEx partner to connect members’ medical records and biometric data
- GSK runs first DTC ad for would-be asthma blockbuster Exdensur
- Novo security breach claimed by hacking groups seeking multi-million-dollar ransoms: reports
- After FDA sign-off, Colorado's drug import plan faces tough road ahead
- Lower Risk Of Death, Clots Among Autoimmune Patients Taking GLP-1 Drugs
- Surgical Menopause Tied To Worse Sexual And Urinary Symptoms
- Post-Op Delirium Common In Seniors, But Not All Hospitals Screen For It
- Nortiva purrs into action with long-acting Lynx platform salvaged from Langer startup
- Weekly Rundown: Lumeris adds symptom-checking tool to AI platform; DeepIntent rolls out agentic AI tool for healthcare marketers
- Before you build or buy care navigation AI, answer this
- Early-Onset Cancers Are On The Rise. Knowing Your Family History Is Crucial.
- Minimally Invasive Procedure Eases Arthritis Knee Pain, Study Finds
- Democrats Seek To Spotlight Rising Health Costs by Forcing Vote on Trump Regulation
- More Americans Are Surviving Cancer. But the Mental Health Challenges Can Persist.
- Tennessee Pharmacies Sell Potent Ivermectin, Led by Anti-Vaccine Doctor Who’s Taken ‘Bucketloads’
- Big Pharma’s Big Brand: Inside Eli Lilly’s marketing culture
- CDC, FDA Tackle New World Screwworm, Including Drug Authorization
- 'Biopharma ecosystem is back to full health,' fueled by M&A: PwC
- Lifestyle Changes Can Reduce Your Risk For Multiple Chronic Diseases
- FDA, UK drug regulator deepen transatlantic ties with new liaison program
- People Walk, Exercise Less After Starting Ozempic, Zepbound
- Family Finances Shape Children’s Brain Development, Study Finds
- At-Home Blood Pressure Monitoring Reduces Risk of Heart Attack, Stroke
- Moderna hires Novartis vet to lead commercial, upsizes role for Hoge as potential launches loom
- Long-Awaited Rule Aims To Boost ACA Choices While Embracing Higher Deductibles
- Many Men Are Prescribed Testosterone Without Proper Testing
- Recipharm channels ‘multi-million-dollar' US manufacturing upgrade, targeting domestic biologics demand
- Organic Baby Formula Recalled Following Botulism Cases
- FDA Approves First Over-the-Counter Glucose Monitor for Children, The Stelo Glucose Biosensor System
- You've Won The Game
- Many Patients Stop And Restart GLP-1 Meds, Study Finds
- Half Of U.S. Parents Track Their Adult Children’s Location
- Taking GLP-1s While On BP Meds May Up Your Risk Of Dizzy Spells, Fainting
- Trust In CDC Plummets Under Trump Administration, New Poll Shows
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- Beyond China and Japan: How biopharma is expanding rare disease access across Asia-Pacific
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- “Harmonization: We’ll Have Lots to Talk About”
- Remarks at the Investor Advisory Committee Meeting
- A Quarter for Your Thoughts: Remarks at the Meeting of the SEC Investor Advisory Committee
Michigan healthcare freedom community forum
The White House withdrew its nomination of Dr. Dave Weldon, a former Florida congressman, shortly before his scheduled appearance before the Senate Health, Education, Labor and Pensions Committee on Thursday. An anonymous White House official has said that Weldon didn't have the votes needed for confirmation by the Senate. Dr. Weldon wrote a four-page statement which was published by The Washington Post and The New York Times.
Big Pharma and the American Public Health Association were opposed to Dr. Weldon because he brought attention to research linking the MMR vaccine and IBD in children.
Jennifer Galardi of the Epoch Times wrote the most complete post mortem of Dr. Weldon's CDC nomination:
https://thefederalist.com/2025/03/14/scuttled-cdc-pick-slams-big-pharma-and-senators-on-its-payroll/
Scuttled CDC Pick Slams Big Pharma And Senators On Its Payroll
By Jennifer Galardi - March 14, 2025In a statement released on the day of his abruptly canceled confirmation hearing, Dr. Dave Weldon, President Trump’s initial nominee to lead the Centers for Disease Control and Prevention, said concerns that Big Pharma was behind the subversion were “probably true.”
“They are hands-down, the most powerful lobby organization in Washington DC giving millions of dollars to politicians on both sides of the aisle,” he wrote.
Weldon said that Wednesday evening, before the morning of his hearing before the Senate Health, Education, Labor, and Pensions (HELP) committee, he had received a call from a White House assistant telling him his nomination had been withdrawn due to a lack of affirmative votes.
According to Weldon’s statement, Health and Human Services Secretary Robert F. Kennedy Jr. told him Sen. Susan Collins of Maine suddenly “had reservations” about confirming him despite having “a very pleasant meeting” with Weldon previously.
“I can assume that the White House staff had my nomination withdrawn also because the Republican Chairman Dr. Bill Cassidy of Louisiana was also voting no,” Weldon wrote.
His claim that “politicians on both sides of the aisle” receive millions of dollars from pharmaceutical companies and lobbyists is undoubtedly true. Pharmaceutical companies spend almost $300 million on lobbying, far outpacing competitors such as the electronics manufacturing industry and insurance companies.
Why might Big Pharma have an interest in pressuring members of Congress to deny Weldon the job? You don’t have to look very far for the answer. Just review the hearings of every health official Trump has nominated to a cabinet position over the past month or so and count how many times “anti-vax” is said.
As a congressman from Florida 25 years ago, Weldon had the “temerity,” as he said in his letter, to question the pharmaceutical companies on what he called two “critical childhood vaccine safety issues.” Weldon said he, like Kennedy, had been approached by hundreds of parents insisting that vaccines had caused injuries, including autism, to their children. Back then, the concern was over a mercury-based preservative in the vaccines known as thimerosal, which is considered a neurotoxin.
Eventually the CDC and pharmaceutical companies agreed to remove thimerosal, though the preservative is still allowed in small amounts in some flu vaccines. The AI overview that pops up in a Google search claims “Extensive scientific research … has concluded that there is no credible evidence linking thimerosal to autism or other neurodevelopmental disorders.” Could it be because the major scientific and medical bodies were incentivized not to find credible evidence?
Weldon asserted that when the “CDC ended up publishing a research study claiming the mercury had done no harm,” there were “credible accusations that CDC had incorrectly manipulated the data to exonerate themselves.”
Weldon also took on the MMR (measles, mumps, rubella) shot, according to his letter, after coming across research by British pediatric gastroenterologist Andrew Wakefield suggesting that many children had suffered a form of inflammatory bowel disease upon taking the MMR shot.
Wakefield sent samples to Irish virologist John O’Leary, “who was able to show … that the inflammatory bowel disease biopsies in these children contained the vaccine strain measles viruses,” Weldon wrote. The theory was that it “also might have been affecting their central nervous system and causing the autistic features.”
Measles cases rose after parents became hesitant to give their kids the MMR shot, due to Wakefield and O’Leary’s research. Essentially, Weldon concluded, O’Leary was pressured to retract his findings and Wakefield lost his medical license.
Weldon believes these two objections killed his shot at being CDC director. He has forever been tarnished as an “anti-vaxxer” despite his insistence that he just wants solid, unbiased research done on the safety of vaccines.
“I have learned the hard way don’t mess with Pharma,” he wrote.
It raises the question: Can Big Pharma be beaten? Can Kennedy and his cohorts at the multiple health agencies really change the way people view health? The entire medical-industrial complex includes not only pharmaceutical companies, but hospitals, insurance companies, and even large food conglomerates, and it propels a good chunk of the American economy.
According to the Census Bureau’s 2019 American Community Survey (ACS), the healthcare industry employs 22 million workers, or 14 percent of the American workforce. Healthcare employment growth is projected to exceed the national average, even though access to primary care physicians is decreasing, suggesting growth in medical bureaucracy and administration rather than direct care providers.
People seem to forget that sickness is a very lucrative business. Pharmaceutical companies, more than any other industry in the medical establishment, are selling you a product. They pressure you to buy — and doctors to sell — their products through commercials, complete with musical dance numbers.
Pharmaceutical companies spend a lot of money researching why people might be hesitant to inject a vaccine into their body, so they can better shut down those concerns. However, according to a report in The Washington Post last week, the NIH will be terminating or limiting grants to fund research related to vaccine hesitancy. It’s a good first step to undoing the propaganda consistently forced down our throats when it comes to so-called healthcare.
Dave Weldon would have been an excellent choice to continue that trend at the CDC. Let’s hope President Trump will find someone equally courageous to follow in his footsteps — someone who can’t be purchased.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.





















